KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Elanco Animal Health (ELAN) Revenue (2017 - 2026)

Elanco Animal Health's Revenue history spans 9 years, with the latest figure at $1.1 billion for Q4 2025.

  • On a quarterly basis, Revenue rose 12.16% to $1.1 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $4.7 billion, a 6.22% increase, with the full-year FY2025 number at $4.7 billion, up 6.22% from a year prior.
  • Revenue hit $1.1 billion in Q4 2025 for Elanco Animal Health, up from $1.1 billion in the prior quarter.
  • Over the last five years, Revenue for ELAN hit a ceiling of $1.3 billion in Q2 2021 and a floor of $985.0 million in Q4 2022.
  • Historically, Revenue has averaged $1.1 billion across 5 years, with a median of $1.1 billion in 2025.
  • Biggest five-year swings in Revenue: skyrocketed 118.09% in 2021 and later fell 11.42% in 2022.
  • Tracing ELAN's Revenue over 5 years: stood at $1.1 billion in 2021, then decreased by 11.42% to $985.0 million in 2022, then grew by 5.08% to $1.0 billion in 2023, then fell by 1.45% to $1.0 billion in 2024, then grew by 12.16% to $1.1 billion in 2025.
  • Business Quant data shows Revenue for ELAN at $1.1 billion in Q4 2025, $1.1 billion in Q3 2025, and $1.2 billion in Q2 2025.